CytoSorbents (CTSO) announces new real-world CABG bleeding data
CytoSorbents said new real-world data show a significant reduction in severe bleeding using CytoSorb in CABG patients on ticagrelor. It also updated DrugSorb-ATR FDA pre-submission meetings.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.